Standard SPAC IPO amendment with no material changes from prior filing. No target identified yet. Monitor for the EFFECT notice signaling the offering is priced and for future 8-K filings announcing trust account receipt and eventual business combination target. Units expected to trade under JABU, with components under JAB, JABW, JABRR after separation.
Executive Summary
JAB Acquisition Corp I filed Amendment No. 2 to its S-1 registration statement for a SPAC IPO, dated June 5, 2026. The company is offering 15,000,000 units at $10.00 per unit, with each unit consisting of one Class A ordinary share, one warrant (exercise price $11.50), and one right to receive 1/4 of a Class A ordinary share upon a business combination. The sponsor is purchasing 260,000 private units simultaneously. Gross proceeds of $150M ($172.5M with over-allotment) will be placed in trust, with a 12-month completion window extendable by up to two three-month periods. This is a procedural amendment with no material changes from prior filings — no target has been selected.
Key Financial Metrics
Key Facts
- Offering 15,000,000 units at $10.00/unit, each unit = 1 Class A share + 1 warrant ($11.50 strike) + 1 right (1/4 share upon business combination)
- Underwriters have 45-day option for up to 2,250,000 additional units
- Sponsor JAB Acquisition Sponsor I, LLC purchasing 260,000 private units at $10.00/unit ($2.6M total)
- Gross proceeds of $150M ($172.5M with over-allotment) deposited in trust account
- 12 months to complete initial business combination, extendable by up to two three-month periods with $0.10/share deposit each
- Sponsor holds 9,857,143 founder shares purchased for $25,000 ($0.002/share); up to 1,285,714 subject to forfeiture if over-allotment not exercised
- Management targets enterprise value of $200M or greater; focus on technology, healthcare, and logistics
- No target selected and no substantive discussions initiated with any target
Financial Impact
IPO gross proceeds of $150,000,000 (or $172,500,000 with over-allotment) to be held in trust. Sponsor investing $2,600,000 in private units. Estimated offering expenses of $1,655,000 leave ~$945,000 in working capital outside trust.
Risk Factors
- No operating history and no revenue — entirely dependent on finding and completing a business combination within 12-18 months
- Significant dilution risk: sponsor's founder shares purchased at $0.002/share vs. $10.00 public offering price, creating misaligned incentives
- If no business combination completed, trust proceeds returned to public shareholders but warrants and rights expire worthless
- Competition from other SPACs and acquisition vehicles for attractive targets
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| S-1/A Filing (Primary) | 0001213900-26-065480 |
| Document: 0001213900-26-065480-index-headers.html | 0001213900-26-065480 |
| Document: 0001213900-26-065480-index.html | 0001213900-26-065480 |
| Document: 0001213900-26-065480.txt | 0001213900-26-065480 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 4, 2026 12w ago | 8-K | — | awaiting T+20 | — | — |
Jun 12, 2026 19w ago | 8-K | — | awaiting T+20 | — | — |
Jun 10, 2026 19w ago | 424B4 | — | awaiting T+20 | — | — |
Jun 10, 2026 19w ago | EFFECT | — | awaiting T+20 | — | — |
Jun 9, 2026 19w ago | 3 | — | awaiting T+20 | — | — |
Jun 9, 2026 19w ago | 3 | — | awaiting T+20 | — | — |
Jun 5, 2026 20w ago | S-1/A | — | awaiting T+20 | — | — |
Jun 5, 2026 20w ago | S-1/A | — | awaiting T+20 | — | — |
May 29, 2026 21w ago | S-1/A | — | awaiting T+20 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers